These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5595511)

  • 21. Bladder carcinoma associated with cyclophosphamide therapy for ovarian cancer occurring with a latency of 20 years.
    Volm T; Pfaff P; Gnann R; Kreienberg R
    Gynecol Oncol; 2001 Jul; 82(1):197-9. PubMed ID: 11426986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients.
    Ghiringhelli F; Menard C; Puig PE; Ladoire S; Roux S; Martin F; Solary E; Le Cesne A; Zitvogel L; Chauffert B
    Cancer Immunol Immunother; 2007 May; 56(5):641-8. PubMed ID: 16960692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experiences with the endoxan intensive therapy of malignant tumors].
    Gebhardt KH; Becher R
    Med Welt; 1966 Apr; 17():973-6. PubMed ID: 5985776
    [No Abstract]   [Full Text] [Related]  

  • 24. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
    Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
    J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies for the understanding of problems of the radiologic-cytostatic combination treatment. 2. Further syncytostatic studies with endoxan].
    Ringleb D
    Strahlentherapie; 1968 Jun; 135(6):681-7. PubMed ID: 5682132
    [No Abstract]   [Full Text] [Related]  

  • 26. [Toxicity and side effects of cyclophosphamide].
    García Dadoni L; Rafael Seoane M
    Rev Clin Esp; 1968 Apr; 109(1):11-6. PubMed ID: 5738821
    [No Abstract]   [Full Text] [Related]  

  • 27. [Problems of clinical cancerology: cytostatic shock with cyclophosphamide].
    Cittadini G
    Minerva Med; 1966 May; 57(39):1715-23. PubMed ID: 5939618
    [No Abstract]   [Full Text] [Related]  

  • 28. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.
    Faurschou M; Sorensen IJ; Mellemkjaer L; Loft AG; Thomsen BS; Tvede N; Baslund B
    J Rheumatol; 2008 Jan; 35(1):100-5. PubMed ID: 17937462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent, moderate-dose cyclophosphamide administration improves the efficacy of cytochrome P-450/cytochrome P-450 reductase-based cancer gene therapy.
    Jounaidi Y; Waxman DJ
    Cancer Res; 2001 Jun; 61(11):4437-44. PubMed ID: 11389073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose metronomic combined with intermittent bolus-dose cyclophosphamide is an effective long-term chemotherapy treatment strategy.
    Shaked Y; Emmenegger U; Francia G; Chen L; Lee CR; Man S; Paraghamian A; Ben-David Y; Kerbel RS
    Cancer Res; 2005 Aug; 65(16):7045-51. PubMed ID: 16103050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [On the treatment of the life threatening bladder hemorrhage caused by cytostatic therapy].
    Nagel R; Baumgärtel H
    Urologe; 1968; 7(2):94-5. PubMed ID: 5658252
    [No Abstract]   [Full Text] [Related]  

  • 32. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Postoperative complications and histological findings in vterine cervix carcinoma after additional cytostatic therapy].
    Schüssling G; Möbius G; Püschel W
    Geburtshilfe Frauenheilkd; 1968 Jul; 28(7):617-30. PubMed ID: 5681959
    [No Abstract]   [Full Text] [Related]  

  • 34. [Middle-high dose of cyclophosphamide or conventional routine chemotherapy with increased dose of cyclophosphamide combined with G-CSF for mobilizing peripheral blood progenitor cells in patients with tumor].
    Lu DP; Liu KY; Guo NL; Shi YK; He XH; Lou FD; Da WM; Zhang BL; Wang LX; Ke XY
    Zhonghua Xue Ye Xue Za Zhi; 2003 Feb; 24(2):68-70. PubMed ID: 12697098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)].
    Schnabel R; Jungstand W; Gutsche W; Grimm H; Fritsch S
    Acta Biol Med Ger; 1967; 19(4):543-58. PubMed ID: 5596676
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of disulfiram on cyclophosphamide toxicity: a clinical trial.
    Ershler WB; Hacker MP; Newman RA; Stewart JA; Gamelli RL; Krakoff IH
    Cancer Treat Rep; 1983 Dec; 67(12):1145-7. PubMed ID: 6652633
    [No Abstract]   [Full Text] [Related]  

  • 37. Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401.
    Brandberg Y; Michelson H; Nilsson B; Bolund C; Erikstein B; Hietanen P; Kaasa S; Nilsson J; Wiklund T; Wilking N; Bergh J;
    J Clin Oncol; 2003 Oct; 21(19):3659-64. PubMed ID: 14512398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of cyclophosphamide on spontaneous testicular and pancreatic lesions in WBN/Kob rats].
    Sato M; Furukawa F; Nishikawa A; Imazawa T; Yoshimura H; Suzuki J; Nakamura K; Takahashi M
    Eisei Shikenjo Hokoku; 1993; (111):34-8. PubMed ID: 7920565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
    Hudis CA; Seidman AD; Baselga J; Raptis G; Lebwohl D; Gilewski T; Currie V; Moynahan ME; Sklarin N; Fennelly D
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Weekly cyclophosphamide pulse therapy combined with corticosteroids in the treatment of pemphigus].
    Jia GQ; Chen ZQ; Li HL; Cui PG; Xu WY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):173-5. PubMed ID: 12905897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.